GLP-1

New Business

Pfizer’s Metsera acquisition to spur Chinese search for next-generation weight-loss drugs

American pharmaceutical giant Pfizer’s up to US$7.3 billion acquisition of next-generation weight loss drugs developer Metsera will encourage more research…

Read More »
New Business

China has 60 drugs under trial to rival Ozempic in US$150 billion weight-loss market

When Hong Kong office worker W.K. Chan began putting on weight as a teenager, her doctor said it was due…

Read More »
New Business

‘China’s Ozempic’ may vie with Eli Lilly, Novo Nordisk for global weight-loss drug market

The global market for diabetes drugs used for treating obesity is expected to expand in Asia, as new players jostle…

Read More »
Back to top button